Mice with BDNF haploinsufficiency exhibited obesity and elevated levels of GLU [10], whereas systemic peripheral administration of BDNF contributed to the improvement of GLU metabolism and prevented the development of diabetes [43], [44]. Here, BDNF is linked to obesity due to melanocortin 4 receptor deficiency.